Skip to main content
. 2018 May 23;24(1):38–46. doi: 10.1634/theoncologist.2017-0622

Table 3. Biomarker evaluations.

image

The median OS was not reached in any of the patient populations.

Abbreviations: IGFR1, insulin‐like growth factor 1 receptor; NR, not reached; OS, overall survival; PFS, progression‐free survival; pmTOR, phosphorylated mammalian target of rapamycin; pS6, phosphoS6; SD, standard deviation.